There has been substantial research interest in delivering therapeutic neurotrophic factors directly to the brain for the treatment of Parkinson's Disease (PD) and other movement disorders. Direct infusion of glial cell-line derived neurotrophic factor has been investigated in both pre-clinical models and clinical trials. In this chapter we discuss past and present research investigating the potential of direct drug delivery to the brain for the treatment of PD and other movement disorders.
|Title of host publication||Current Concepts in Movement Disorder Management|
|Editors||A Niranjan, L D Lunsford, R M Richardson|
|Number of pages||10|
|Publication status||Published - Jan 2018|
|Name||Progress in Neurological Surgery|